Permira-backed Dr. Martens targets £3.7B in UK IPO
February 1, 2021
Dr. Martens, the British shoe brand backed by Permira, has priced its shares at 370 pence apiece, the top end of its range, in an IPO that valued the company at £3.7 billion. Shares were up 16% on conditional trading among existing investors, with full market trading beginning Wednesday. The Griggs family sold Dr. Martens to Permira in 2013 for £300 million.